ADVERTISEMENT RETURN TO ISSUEEditorialNEXTAlzheimer's Disease: Development of Disease-Modifying Treatments Is the Challenge for Our GenerationCraig W. LindsleyCite this: ACS Chem. Neurosci. 2012, 3, 11, 804–805Publication Date (Web):November 21, 2012Publication History Published online21 November 2012Published inissue 21 November 2012https://pubs.acs.org/doi/10.1021/cn300190fhttps://doi.org/10.1021/cn300190feditorialACS PublicationsCopyright © 2012 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views1492Altmetric-Citations14LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (133 KB) Get e-AlertscloseSUBJECTS:Cancer therapy,Medicinal chemistry,Peptides and proteins,Pharmaceuticals,Targeting Get e-Alerts
No takes yet. Share an insight, caveat, or question.
Craig W. Lindsley (2012) studied this question.